Conclusions: Systematic TDM with same day real-time dose adaptation was effective in 56 reaching and maintaining therapeutic antibiotic concentrations in infected burn patients, 57 which prevented both over-and under-dosing. A larger multicentric study is needed to further 58 evaluate the impact of this strategy on infection outcomes and the emergence of antibiotic 59 resistance during long-term burn treatment.
INTRODUCTION 74
Sepsis is a major cause of morbidity and mortality among burn patients (1-4). Burn patients 75 often suffer from recurrent infections that are difficult to treat, caused by nosocomial 76 multidrug-resistant microorganisms (5, 6) . The rapid spread of antibiotic resistance is 77 currently a major challenge in burn care. As the number of new anti-infective drugs entering 78 the market is disappointingly low, strategies to preserve the efficacy of currently approved 79 antibiotics are urgently needed (7, 8) . 80
Antibiotic stewardship programs may reduce the selective pressure induced by antibiotic 81 misuse (9). In addition to rapidly identifying bacterial infections, systematically de-escalating, 82 and shortening the duration of antibiotic treatment, these bundles also include the close 83 monitoring of pharmacokinetic-pharmacodynamic (PK-PD) characteristics to further optimize 84 antibiotic treatments while decreasing the risk that resistance will develop (10). 85
Therapeutic drug monitoring (TDM) was introduced into clinical practice primarily to 86 improve efficacy and to limit the toxicity of antibiotics with narrow therapeutic windows 87 (e.g., vancomycin, aminoglycosides). However, with the increasing availability of rapid-88 dosing techniques, the number of drugs that can be measured in the plasma of patients has 89 grown tremendously over the last decade (11). It is currently possible to monitor blood 90 concentrations of antibiotics in real-time to improve efficacy and avoid under-dosing, which 91 can favor bacterial regrowth and the emergence of resistant organisms. Several studies have 92 demonstrated that TDM improves the prescription of antibiotics in various populations of 93 hospitalized patients, including critically ill patients, with a direct impact on outcomes (11-94 6 prospectively. All infection episodes corresponding to a monitored antibiotic course were 131 characterized, as previously described [see supplemental information in (15) until July 2015, all antibiotics were given via 30-minute infusion. In August 2015, the 145 duration of infusion time of β-lactams was increased to 2 hours, starting from the second dose 146 due to an update of local protocols regarding all critically ill patients, including burn patients, 147 receiving β-lactams. Because systematic TDM of aminoglycosides and vancomycin are part 148 of the standard of care at our institution, those treatment courses were not included. 149
150
Intervention 151
After informed consent was obtained, patients were randomized to an intervention group 152 (patients with real-time TDM and online antibiotic adaptation) or to a standard-of-care group 153 (patients for whom antibiotic concentrations would be determined only after completion of 154 7 41-60%, >60%) (Figure 1 and supplemental Figure S1 ). All infectious episodes and 156 antibiotic courses during a given patient's stay were handled according to the initial 157 randomization result. Blood was drawn from each patient every other day (QOD) for TDM 158 until the end of the antibiotic course, but antibiotic concentrations were determined in real-159 time only for patients randomized to the intervention group, for whom the prescription of 160 antibiotics was further adapted the same day according to a standardized adaptation protocol 161 by dedicated independent pharmacologists and infectious disease specialists to meet 162 predefined pharmacodynamic targets (see Supplementary Material adaptation protocol file 163 S1). An every other day TDM regimen was chosen in order to rapidly adjust the antibiotic 164 doses while taking into account the time needed for β-lactams to reach the steady state after 165 dose adaptation. In the standard-of-care group, the prescription of antibiotics was modified at 166 the clinician's discretion. Upon clinician's special request, rescue TDM could however be 167 determined in real-time for any patient randomized to the standard-of-care group. 168
169

Evaluation of trough antibiotic concentrations 170
Antibiotic serum levels were determined (2.7 ml blood samples) by the Laboratory of the 171
Service of Biomedicine at CHUV using a multiplex assay with high-performance liquid 172 chromatography coupled with tandem mass spectrometry (HPLC-MS/MS) according to 173 previously published validated analytical methods with lower limits of quantification of 0.02-174 0.5 mg/L (21, 22). The median total amount of blood withdrawn from each patient reached 175 13.5 ml 8.1; 25.0. 176
Total drugs levels were measured, but estimated unbound concentrations were calculated 177 using available data for protein binding (see our local adaptation protocol file in 178
Supplementary Material S1). Antibiotic serum levels were obtained within 6 hours on the 179 day of the request from Monday to Friday and subsequent adaptation of antibiotic prescription 180 upper limits of trough concentrations were also specified in the adaptation protocol file. 189 190 Doses adaptations were performed using pre-defined "steps". The algorithm is presented in 191 Supplemental Material S1. Briefly, the prescription of the given antibiotic was reduced of 192 one step in case of excessive trough levels < 150% of the upper limit, respectively increase of 193 one step in case of trough levels ranging between 50-100% of the minimal target. 194
Increase/decrease of two steps was apply in case of trough levels exceeding 150-200% of the 195 upper limit, respectively ranging between10-50% of minimal target. 196
197
Outcomes 198
The first predefined primary pharmacokinetic outcomes were the time required to achieve 199 anti-infective serum concentrations within the predefined target range and the proportion of 200 trough antibiotic serum concentration measurements that fell within the target range during a 201 single course of treatment with a given anti-infective agent. 
Statistical analysis 213
Continuous normally and non-normally distributed variables are reported as means ± standard 214 deviations and medians with interquartile ranges (p25; p75), respectively. Categorical 215 variables are reported as frequencies and percentages. An intention-to-treat analysis of all 216 randomized patients was performed for all endpoints. Per-protocol analysis was performed for 217 the main outcomes, excluding unblindings for rescue TDM requests in the standard-of-care 218 group. All analyses were adjusted for burn severity (stratified randomization). Results of 219 unadjusted analyses are also presented. As there were very few patients with TBSA>60% we 220 used 3 levels of burn severity for the analysis: TBSA<20%, 20%-40% and >40%. Difference 221 between groups regarding time to achieve anti-infective concentrations within the predefined 222 target range was assessed using Cox proportional hazards model. Effect of the intervention on 223 the proportion of antibiotic concentration measurements that fell within the target was 224 evaluated with a logistic regression model. To assess the effect of systematic TDM with same 225 day real-time dose adaptation on the frequency of antibiotic concentrations remaining within 226 the predefined target range, we first compared the initial concentrations between groups, 227 before analyzing the impact of intervention on subsequent antibiotic concentration 228 measurements in each randomization group. Difference between groups in terms of 229 proportions of antibiotic concentration measurements above the upper limit or below the 230 were finally randomized to the intervention group and 19 to the control group (Figure 1) . 241
Burn patients' characteristics are presented in 
Characteristics of infectious episodes 248
Among 38 randomized patients, we observed 73 episodes of infection, which accounted for 249 1.9 infection episodes per patient and 41 antibiotic cures per randomization group (Figure 1  250 and Table 2 ). The most frequently encountered infections were pneumonia (n=42, 57.5%) 251 and burn wound infections (n=16, 21.9%) (Tables 2 and 3). There were 62 (84.9%) 252 microbiologically documented infectious episodes, with the following bacteria isolated most 253 frequently: Pseudomonas aeruginosa (n=7, 11.3%), Staphylococcus aureus (n=6, 9.7%), and 254
Streptococcus pneumoniae (n=4, 6.5%) (Figure 2 and Table 2 ). The antibiotics prescribed 255 most commonly were meropenem, amoxicillin, piperacillin-tazobactam, and ceftriaxone 256 ( Table 3 ). The duration of treatment (7 days [4.5; 9]) and antibiotic consumption were similar 257 between groups (Table 3) . 2.16, p=0.341). For 17 antibiotic cures (9 in the standard-of-care group and 8 in the 274 intervention group) there was no other measurement after the first one due to antibiotic 275 switches (de-escalation n=9, escalation n=3), patients' transfers n=4 or end of therapy 276
n=1. 277
Patients in the intervention group spent more days within the predefined target range than did 278 patients in the standard-of-care group (193 This 3-year prospective monocentric, randomized controlled trial demonstrated that real-time 307 TDM with same day dose adaptation was effective in reaching, maintaining therapeutic 308 trough levels and avoiding underdosing in infected burn patients. At initiation of antibiotic 309 therapy, less than 60% of patients had an adequate antibiotic trough level. However, burn 310 patients that benefited from the intervention subsequently spent more days within the 311 predefined target range than did patients treated with the standard-of-care. This effect held 312 true regardless of burn severity. 313
To our knowledge, this is the first randomized prospective study showing that a 314 pharmacokinetic intervention guided on real-time TDM in patients with severe burns 315 requiring admission to the ICU effectively improves the probability of being within 316 therapeutic range during antibiotic treatment. Over a one-year period, Patel et al. conducted a 317 prospective study evaluating the impact of TDM in burn patients treated with β-lactams in a 318 ward environment (25). The authors excluded critically ill burn patients and did not stratify 319 the randomization according to burn severity. The results of the study showed that empiric β-320 lactam dosing did not consistently achieve therapeutic targets and displayed significant 321 variability in trough antibiotic concentrations after burn trauma. 322 323 Our population of burn patients requiring ICU admission was similar to those previously 324 described by others in terms of age, inhalation injury, and burn severity (25-30). As we and 325 others have reported, sepsis after burn trauma is typically caused by pneumonia or infections 326 of burn wounds (31-35). Such infections are typically due to P. aeruginosa and S. aureus (7, 327 8). While broad-spectrum antibiotics are among those prescribed most frequently to fight 328 infection, the use of imipenem-cilastatin in comparison to meropenem was surprisingly 329 uncommon, probably because of the former's greater variability in trough concentration we 330 on February 6, 2018 by Universitaetsbibliothek Bern http://aac.asm.org/ Downloaded from reported (15). Burn trauma differentially affected the pharmacokinetics of highly protein-331 bound antibiotics: while ceftriaxone trough concentrations were mostly within the target 332 range, flucloxacillin trough levels often fell below the predefined target range, probably as a 333 consequence of increased clearance in burn patients (36, 37) . In one case, this effect may have 334 been the result of a physician's underdosage (2 g 3×/day vs. standard recommended dosage of 335 2 g 4-6×/day). 336 337 Our study protocol allowed physicians to ask for rescue TDM in cases of poor clinical 338 evolution. Per physician special request, 6 rescue measurements of trough concentrations 339 were obtained for 3 severely burned patients presenting with affected TBSA ≥60%. These 340 interventions resulted in an increased dose of antibiotics in one case and an antibiotic switch 341 in the second case. These unblinded requests may highlight the importance of TDM in this 342 complex population of patients and suggest that systematic TDM, still available on request for 343 clinicians, has progressively become the standard of care at our BICU, especially after severe 344 burn trauma. After removing these patients from subsequent analyses, per-protocol analysis 345 confirmed the results of the intention-to-treat analysis and the effect of real-time TDM. 346 347 Our study has several strengths. First, it is a prospective and randomized study that included 348 consecutive burn patients admitted to a tertiary hospital BICU over the course of 3 yr. Fourth, as we performed trough levels and not in the mid-interval trough levels, time above 364 MIC could not be estimated. Finally, because we randomized patients rather than infectious 365 episodes to facilitate the acquisition of informed consent, we observed a slight imbalance 366 between groups in the number of trough concentration measurements. This discrepancy may 367 also reflect the antibiotic switch (executed for de-escalation) or the longer duration of 368 antibiotic treatment in patients with drug-resistant bacteria. 369
370
In conclusion, through a 3-year prospective, monocentric, randomized, controlled trial we 371 demonstrated that systematic TDM with same day antibiotic dose adaptation is a feasible and 372 useful intervention in order to overcome pharmacokinetic variability after burn trauma, 373 thereby avoiding antibiotic under-and over-dosage. This monitoring should especially be 374 considered in the subset of patients presenting with augmented renal clearances after burn 375 trauma (40-44). TDM for most β-lactam antibiotics is now routinely available at our BICU, 376 and we further modified our internal guidelines to also perform systematic TDM in other 377 groups of ICU patients, such as those under extracorporeal membrane oxygenation support. Total number of appropriate antibiotic levels (n) Number of appropriate first antibiotic levels (n, %) Number of appropriate subsequent antibiotic levels (n, %) Not appropriate antibiotic levels (n)
Below the predefined target (n, %)
Over the predefined target (n, %)
